Growth Differentiation Factor 9 Inhibits Vascular Endothelial Growth Factor Expression in Human Granulosa Cells.

Congcong Guo,Minghui Chen,Wenmin Ma,Bing Cai,Yanwen Xu,Yiping Zhong,Canquan Zhou
DOI: https://doi.org/10.1080/09513590.2020.1718640
2020-01-01
Gynecological Endocrinology
Abstract:In aortic endothelial cells, the TGF beta signaling pathway is involved in the regulation of vascular endothelial growth factor (VEGF), which encodes a potent angiogenic factor crucial for the development of ovarian hyperstimulation syndrome. Growth differentiation factor 9 (GDF9) is a member of the TGF beta family and its effect on VEGF expression in human granulosa cells is unknown. In this study, human granulosa cells were collected from patients during the course of oocyte retrieval for in vitro fertilization and were cultured in vitro. After the first 48 h of culture, cells were treated with GDF9 with or without SB431542 (an ALK5 inhibitor) at various doses. The medium was then collected to determine the concentration of VEGF by ELISA. Cellular RNA was collected and extracted for quantification by real-time quantitative fluorescence PCR. Our study showed that GDF9 suppressed VEGF release from human granulosa cells in a dose-dependent manner and also downregulated VEGF mRNA levels in these cells. Furthermore, SB431542 antagonized the suppression of VEGF mRNA by GDF9 and diminished the inhibitory effect of GDF9 on VEGF release by human granulosa cells. Our results indicated that GDF9 can inhibit VEGF expression in human granulosa cells and ALK5 might mediate this process.
What problem does this paper attempt to address?